Research Output 1987 2016

Filter
Letter
2008
289 Citations (Scopus)

Six-month randomized, placebo-controlled, double-blind, pilot clinical trial of curcumin in patients with Alzheimer disease [7]

Baum, L., Lam, C. W. K., Cheung, S. K. K., Kwok, T., Lui, V., Tsoh, J., Lam, L., Leung, V., Hui, E., Ng, C., Woo, J., Chiu, H. F. K., Goggins, W. B., Zee, B. C., Cheng, K. F., Fong, C. Y. S., Wong, A., Mok, H., Chow, M. S. S., Ho, P. C. & 8 others, Ip, S. P., Ho, C. S., Yu, X. W., Lai, C. Y. L., Chan, M. H., Szeto, S., Chan, I. H. S. & Mok, V., Feb 1 2008, In : Journal of Clinical Psychopharmacology. 28, 1, p. 110-113 4 p.

Research output: Contribution to journalLetter

Phytotherapy
Curcuma
Curcumin
Hong Kong
Non-Steroidal Anti-Inflammatory Agents
2002
1 Citation (Scopus)

Adequate lymph node staging is fundamental to comparative study on resectable non-small-cell lung cancer [3] (multiple letters)

Mok, T. S., Zee, B. C., Depierre, A., Westeel, V., Milleron, B., Moro-Sibilot, D., Quoix, E., Braun, D. & Lebeau, B., May 15 2002, In : Journal of Clinical Oncology. 20, 10, p. 2604-2605 2 p.

Research output: Contribution to journalLetter

Neoplasm Staging
Non-Small Cell Lung Carcinoma
Lung Neoplasms
Lymph Nodes
17 Citations (Scopus)

Multinomial phase II trial designs [1]

Freidlin, B., Dancey, J., Korn, E. L., Zee, B. & Eisenhauer, E., Jan 15 2002, In : Journal of Clinical Oncology. 20, 2, p. 599 1 p.

Research output: Contribution to journalLetter

Endpoint Determination
Phase II Clinical Trials
Reproducibility of Results
Antineoplastic Agents
Disease Progression

Radiotherapy in soft-tissue sarcoma [21] (multiple letters)

Schultheis, C., Sachs, B., Haider, S., Vaidya, J. S., Palazzo, F. F., O'Sullivan, B., Bell, R., Davis, A., Turcotte, R. & Zee, B. C., Dec 14 2002, In : Lancet. 360, 9349, p. 1988-1989 2 p.

Research output: Contribution to journalLetter

Combined Modality Therapy
Radiation Injuries
Postoperative Period
Sarcoma
Wound Healing
1998
1 Citation (Scopus)

Can the Q-TWIST method provide information on patients' preferences without collecting preference data from the patients? [6] (multiple letters)

Messori, A., Trippoli, S., Zee, B., James, K., Pater, J., Cole, B. F., Gelber, R. D. & Goldhirsch, A., 1998, In : Journal of Clinical Oncology. 16, 11, p. 3716-3718 3 p.

Research output: Contribution to journalLetter

Patient Preference
Adjuvant Chemotherapy
Survival Analysis
Patient Satisfaction
Antineoplastic Agents